O processo de trabalho de um time de medicação na perspectiva de uma pesquisa-ação / The work process of a medication team from an action research perspective

Objetivou-se descrever e analisar o processo de trabalho do time de medicação na unidade de terapia intensiva neonatal. Pesquisa-ação realizada com 21 enfermeiros de uma unidade neonatal de um hospital universitário. Foram realizadas entrevistas, pesquisa documental, observação sistemática e seminários para a coleta e análise temática dos dados. O estudo apontou três categorias: dificuldades encontradas no processo de trabalho do time de medicação; caracterização dos recursos materiais e ambiente de trabalho; padronização do processo de trabalho do time de medicação. As principais barreiras apontadas foram a falta de padronização do processo de trabalho e a ausência e/ou atualização de instrumentos que subsidiam sua prática. Desta forma, a partir das ações do grupo foram elaborados os seguintes produtos: fluxograma do processo de trabalho; construção e padronização de impressos; atualização de Protocolos Operacionais Padrão e atribuições da equipe de enfermagem; padronização de material de almoxarifado, farmácia e apoio.

This study aimed to describe and analyze the work process of the medication team in a neonatal intensive care unit. This action research was carried out with the participation of 21 nurses at a university hospital neonatal unit. Interviews were conducted, along with documental research, systematic observation and workshops for data collection and thematic analysis. The study indicated three categories: difficulties encountered in the work process of the medication team; description of material resources and working environment; and standardization of the work process of the medication team. The principal barriers indicated were lack of standardization of the work process and the absence and/or updating of instruments supporting work practices. As such, the following products were elaborated from the group actions: work process flowchart; development and standardization of printouts; updating of Standard Operational Protocols and duties of the nursing team; and standardization of storeroom, pharmacy and support material.

Ações para segurança na prescrição, uso e administração de medicamentos em unidades de pronto atendimento / Acciones para la seguridad en la prescripción, consumo y administración de medicamentos en una unidad de pronta atención / Actions for safety in the prescription, use and administration of medications in emergency care units

Resumo OBJETIVO Identificar os riscos e incidentes relacionados ao processo de terapia medicamentosa no cenário de uma Unidade de Pronto Atendimento (UPA) e propor ações de gerenciamento e práticas seguras, na percepção da equipe de enfermagem. MÉTODO Pesquisa qualitativa, na modalidade pesquisa-ação, desenvolvida no cenário de uma UPA, localizada no interior de São Paulo. A coleta dos dados foi realizada por meio de entrevistas e grupos focais com 33 profissionais, entre junho de 2015 a abril de 2016. Para o tratamento dos dados utilizou-se a Técnica de Análise de Conteúdo. RESULTADOS E DISCUSSÃO A partir dos relatos dos participantes foram organizadas categorias temáticas, sendo os riscos e incidentes relacionados ao processo de terapia medicamentosa uma das categorias elencadas, assim como propostas de ações. CONCLUSÃO O estudo possibilitou a implementação de ações de segurança ao paciente relacionadas à administração de medicamentos em uma UPA, oferecendo maior qualidade do cuidado.

Resumen OBJETIVO Identificar cuáles son los riesgos e incidentes relacionados con el proceso de terapia medicamentosa en una Unidad de Pronta Atención (UPA) y presentar propuestas de acciones de gestión y prácticas seguras en la percepción del equipo de enfermería. MÉTODO Investigación cualitativa, en la modalidad investigación-acción, desarrollada en el escenario de una UPA, ubicada en el interior de San Pablo. Se recolectaron los datos a través de entrevistas y grupos focales con 33 profesionales, entre junio de 2015 y abril de 2016. Para procesar los datos, se utilizó la Técnica de Análisis de Contenido. RESULTADOS Y DISCUSIÓN A partir de los relatos de los participantes, se organizaron categorías temáticas, siendo los riesgos e incidentes relacionados al proceso de terapia medicamentosa una de las categorías enumeradas, así como las propuestas de acciones. CONCLUSIÓN El estudio permitió implementar acciones de seguridad del paciente relacionadas con la administración de medicamentos en una UPA, ofreciendo mayor calidad del cuidado.

ABSTRACT Objective: To identify what risks and incidents related to the drug therapy process are presented in an Emergency Care Unit (UPA) and to present proposals for management actions and safe practices, in the perception of the nursing team. Method: Qualitative research, in the research-action modality, developed in the scenario of UPA, located in the interior of São Paulo. Data collection was done through interviews and focus groups with 33 professionals, between June 2015 and April 2016. For the data treatment, the Content Analysis Technique was used. Results and discussion: From the participants' reports, thematic categories were organized, with the risks and incidents related to the drug therapy process being one of the listed categories, as well as proposals for actions. Conclusion: The study allowed the implementation of patient safety actions related to the administration of drugs in a PAU, offering a higher quality of care.

Aplicación del modelo de gestión por procesos: el caso de la distribución y dispensación de medicamentos en dosis unitaria diaria. Hospital Italiano Monte Buey. Año 201-2013

La distribución y dispensación de medicamentos de uso hospitalarioconstituyen una oportunidad de mejora.Un buen manejo de medicamentos hospitalarios representa unanecesidad para un adecuado y oportuno acceso al paciente que lorequiera.Este trabajo busca realizar un estudio que pueda promover unaadecuada administración en la distribución y dispensación demedicamentos en el ámbito de la farmacia intrahospitalaria delHospital Italiano Monte Buey que permita garantizar la seguridaddel paciente mediante el uso racional y eficiente de los mismosfavoreciendo así la calidad de la atención.El presente estudio se enmarca dentro de la investigación científica,explorativa, descriptiva de corte transversal de naturaleza aplicada.La identificación de los distintos procesos – de gestión - clave y deapoyo, que se integran en la logística de distribución y dispensacióninterna de la Farmacia intrahospitalaria, luego de revisar los distintossistemas de distribución interna con sus ventajas y desventajas, permitenla elaboración del mapa de procesos de la misma con sus correspondientesfichas de proceso y diagrama de flujo.De los resultados obtenidos al analizar el movimiento deampicilina – sulbactam dispensados en el trimestre luego de lapuesta en marcha del sistema de distribución de medicamentos endosis unitaria diaria, se demuestra que se consumieron 91,28% deltotal distribuidos recuperando un 8,71% no utilizados que retornana farmacia, quedando expresado el beneficio del modelos de gestiónpor procesos propuesto con intervención del farmacéutico en lainterpretación del pedido médico, recupero de medicación condisminución del stock y del gasto al no solicitar nuevas compras,todo lo cual impactan en eficiencia y seguridad con eficacia en ladispensación de los medicamentos.

The distribution and dispensation of the medicinal products forhospital use constitute an opportunity for improvement.Good management of hospital drugs represents a need for proper andtimely access to the patient who requires it.This work intends to conduct a study which to promote a properadministration in the distribution and dispensation of medicinalproducts in the hospital pharmacy of Hospital Italiano Monte Buey,that would ensure the safety of the patient through the rational andefficient use of them, favouring the quality of care.This study falls within the scientific, exploratory, descriptive researchof cross section of applied nature.The identification of the various processes – management – keyand support, integrated in the logistic distribution and internalhospital pharmacy dispensation, after reviewing the different systems ofinternal distribution with its advantages, allow the development ofthe process map with its corresponding data sheets of process andflowchart.The results obtained from analyzing the movement of ampicilin –sulbactam dispensed in the quarter after the implementation of thesystem of distribution of drugs in unit dose dayli, is shown that theywere consumed 91,28% of the total distributed recovering 8,71%unused returning to pharmacy, being expressed to the benefit ofthe process management models propored with intervention of thepharmacist in the interpretation of the ordering physician, recoveryof medication with stock and costs decrease by not requesting newpurchases, all which have an impact on efficiency and securityeffectively in the dispensation of drugs.

Segurança na administração de medicamentos em pediatria / Safety in medication administration in pediatrics

Erros ou falhas podem ocorrer em qualquer fase do sistema de medicação. Em crianças, fatores como idade, peso, estatura, condições clínicas, características do metabolismo e escassez de medicamentos direcionados para a população pediátrica contribuem para a ocorrência de erros de medicação. Este artigo teve como objetivos, apresentar aspectos relevantes do sistema de medicação e recomendações para a redução de erros de medicação em crianças, com fundamentação nos princípios da segurança do paciente em pediatria.

Errors or failures can occur at any phase of the medication administration system. In children, factors such as age, weight, height, medical conditions, metabolic characteristics and lack of targeted drugs for the pediatric population contribute to the occurrence of medication errors. This article presents relevant aspects of the medication system and recommendations for reducing medication errors in children, with a foundation in the principles of patient safety in pediatrics.

Errores o fallas pueden suceder en cualquier fase del sistema de medicación. Tratándose de niños, fatores como edad, peso, estatura, condiciones clínicas, características del metabolismo y escasez de medicamentos dirigidos a la población pediátrica contribuyen en la ocurrencia de errores de medicación. En este artículo se tuvo como objetivos, presentar aspectos relevantes del sistema de medicación y recomendaciones para la reducción de errores de medicación en niños, fundamentados en los principios de la seguridad del paciente en pediatría.

Farmacovigilancia activa en pacientes afiliados al sistema general de seguridad social en salud / Active pharmacosurveillance of patients affiliated to the Colombian general social security/health system

Objetivos Determinar los posibles resultados negativos asociados a la medicación mediante la metodología de búsqueda activa de posibles interacciones medicamentosas en bases de datos de pacientes afiliados al Sistema General de Seguridad Social en Salud. Métodos A partir de las bases de datos de dispensación de medicamentos de Audifarma S.A a unos 4 millones de usuarios del país, se hizo una revisión sistemática de estadísticas de una serie de medicamentos identificados por presentar interacciones de riesgo, dosis diferentes a las recomendadas o dispensación irregular. Los casos son socializados con las EPS responsables. Resultados Se encontró un caso de nefrotoxicidad por ácido zoledrónico; el 37,0 por ciento de los usuarios de clopidogrel recibían concomitantemente omeprazol, que reduce la efectividad del primero; el 29,9 por ciento de los pacientes que toman losartan están recibiendo dosis superiores a las recomendadas para su indicación; el 2,0 por ciento de los pacientes que toman metoprolol o verapamilo, los recibe simultáneamente, con riesgo de generar bradicardia sinusal, bloqueos auriculoventriculares o disfunción sistólica. Todos los casos fueron notificados a los responsables en la EPS que atienden estos pacientes. Discusión La farmacovigilancia activa permite optimizar recursos, prevenir eventos adversos que puedan potencialmente causar morbilidad importante o incluso letalidad o determinar problemas que podrían ser responsables del fracaso terapéutico. Este tipo de estrategia se anticipa a la aparición de posibles riesgos para el paciente por lo que se recomienda considerarla para reforzar los programas de vigilancia de uso de medicamentos en el país.

Objectives Determining negative results associated with medication through an active search of possible drug interactions in databases for patients affiliated to the Colombian general social security/health system. Methods Statistics related to Audifarma S.A. dispensation drug databases for about 4 million Colombian users were systematically reviewed for identifying drugs having known interactions involving risk, doses different from recommended ones or irregular dispensation. The pertinent health-care providing services were made aware of the above. Results There was one case of nephrotoxicity being caused by zoledronic acid. 37 percent of clopidogrel users concomitantly received omeprazole which reduces the former's effectiveness. 29.9 percent of patients who were taking losartan were receiving doses higher than the recommended ones. 2.0 percent of patients who were taking metoprolol or verapamil were simultaneously receiving them, at the risk of generating first-degree heart block, bradycardia, or systolic dysfunction. All these cases were notified to the pertinent health-care services. Conclusions Active pharmacosurveillance leads to resources being optimised, adverse events which can potentially cause morbidity or lethality being prevented or even determining problems which could be responsible for therapeutic failure. This type of strategy anticipates the appearance of possible risks for patients, meaning that drug use monitoring programmes in Colombia should be reinforced.

Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.

BACKGROUND & OBJECTIVES: The mass drug administration (MDA) is one of the strategies to eliminate lymphatic filariasis in India. Eleven districts are endemic for the disease in Madhya Pradesh state of India, which conduct MDA activities annually. A mid-term evaluation was conducted with the objectives to review the progress of the single dose of di-ethyl-carbamazine (DEC) administration, and to understand the functioning of the programme to recommend mid-term amendments. METHODS: A qualitative cross-sectional study was conducted in three endemic districts of Madhya Pradesh between July and October 2007. The teams of faculty members from medical college visited the study districts and collected data by desk review, indepth interviews, on site observations, and from the community. RESULTS: The filaria units in these districts were understaffed. There were no night clinics in two out of the three districts. The sufficient number of trainings for MDA were conducted without any mechanism for quality assurance. There was erratic and inadequate supply of DEC tablets, leading to the postponement of MDA activity, twice. The evaluated coverage with DEC tablets was much lower than that reported by the district officials. The tablet intake was not ensured by the distributors and the compliance rate was in the range of 60-70%. The IEC activities were conducted in limited areas, and there were prevailing myths and misconceptions, contributing to low compliance rate. There was no proper recording of the data on filariasis with gross mismatch at district headquarters and peripheral health facilities. A proportion of community members developed side effects following DEC tablet intake and had to visit private health facilities for treatment. INTERPRETATION & CONCLUSION: This evaluation study noted that MDA is restricted to tablet distribution only and the major issues of implementation in compliance, health education, side effect and morbidity management, and the logistics were not being given due attention. The implementation should be strengthened immediately in the MDA programme in India to achieve the goal of LF elimination by 2015.

Incapacidade temporária para atividades habituais: relação com a pressão arterial e o uso de terapia farmacológica anti-hipertensiva no Estudo Pró-Saúde / Temporary disability for daily activities: relationship with the blood pressure and use of anti-hypertensive drug therapy in the Pró-Saúde study

A hipertensão arterial (HA) desempenha papel determinante na ocorrência de eventos clínicos graves, havendo entretanto controvérsias quanto ao seu impacto no cotidiano do portador. A incapacidade temporária para a realização de atividades habituais definida como uma restrição temporária na capacidade funcional habitual do indivíduo, é um indicador de saúde recomendado pela Organização Mundial da Saúde para uso em estudos populacionais. A partir do objetivo geral de investigar a associação entre hipertensão arterial e incapacidade temporária para atividades habituais, delineamos os seguintes objetivos específicos: A) Investigar se a elevação dos níveis pressóricos determina a freqüência e o período acumulado de incapacidade temporária para atividades habituais; B) Investigar se o uso de medicações anti-hipertensivas associa-se a alterações na freqüência e no período acumulado de incapacidade temporária para atividades habituais. Estudo seccional com dados de 2953 participantes obtidos de questionário auto-administrado no Estudo Pró-Saúde, uma coorte de funcionários técnicos administrativos de universidade localizada no estado do Rio de Janeiro. A exposição foi avaliada a partir do valor aferido da PA e do uso de drogas anti-hipertensivas. Conduzimos a análise separando os participantes em 4 grupos, combinando as informações quanto à PA aferida...

Arterial hypertension (AH) plays a determinant role in the occurrence of severe clinical events; however, there are controversies about its impact on daily life. The temporary disability for daily activities, which is defined as a temporary restriction in an individual’s usual level of functioning, is a health indicator proposed by the World HealthOrganization for utilization in population studies. Objectives: To investigate the association between arterial hypertension and temporary disability for daily activities, we proposed thefollowing specific objectives: A) To investigate whether elevated blood pressure (BP) determine the frequency or accumulated period of temporary disability for daily activities; 2) To investigate whether the use of anti-hypertensive drugs are associated with changes in the frequency or accumulated period of temporary disability for daily activities. Methods: Across-sectional study with data obtained from 2953 participants who answered a selfadministered questionnaire in the Pro-Saude Study, a cohort of university emplyees in Rio de Janeiro state. The exposure was evaluated using the measured value of BP and the report ofthe use of anti-hypertensive drugs. We conducted the analysis classifying the participants in 4 groups, combining the information about measured BP (< or ³ 140/90 mmHg) and the report of the use of anti-hypertensive drugs or not. The outcome was evaluated with a composite variable with information about the report and period of disability. Multivariate analyses were conducted using multinomial logistic regression. Results: 690 (23.4 %) were classified as hypertensives, and 704 (23.8 %) reported temporary disability. The use of anti-hypertensive drugs, among the participants with BP < 140/90 mmHg, was directly associated with theprevalence of temporary disability for daily activities for a longer period (OR=2.25, CI 95 %: 1.31 - 3.87)...

Drug procurement and management.

A strong drug procurement and management system under the RNTCP is critical to programme success. Significant improvements in manufacturing, inspection, supply, storage and quality control practices and procedures have been achieved due to an intensive RNTCP network. Drugs used in RNTCP are rifampicin, isoniazid, ethambutol, pyrazinamide and streptomycin. Patients of TB are categorised into I, II and III and each category has a different standarised treatment. Procurement, distribution system and quality assurance of drugs are narrated in brief in this article.